Santhera Pharmaceuticals Holding AG
F:S3F
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Santhera Pharmaceuticals Holding AG
F:S3F
|
CH |
|
Tesla Inc
MIL:1TSLA
|
US |
|
Chalet Hotels Ltd
NSE:CHALET
|
IN |
|
O
|
O'Reilly Automotive Inc
F:OM6
|
US |
|
Radiant Logistics Inc
F:3GT
|
US |
|
F
|
Fresenius SE & Co KGaA
XBER:FRE
|
DE |
|
A
|
AP Moeller - Maersk A/S
DUS:DP4B
|
DK |
|
Netlinkz Ltd
ASX:NET
|
AU |
|
T
|
Texas Roadhouse Inc
F:ROW
|
US |
|
C
|
Clean Teq Water Ltd
F:9NK
|
AU |
|
H
|
Halfords Group PLC
F:HDK
|
UK |
|
American Financial Group Inc
NYSE:AFG
|
US |
|
T
|
Telecom Italia SpA
BMV:TIT
|
IT |
|
D
|
DBV Technologies SA
SWB:DBV
|
FR |
|
K
|
Koninklijke Philips NV
XHAM:PHI1
|
NL |
|
A
|
Alibaba Group Holding Ltd
F:2RR
|
CN |
|
L
|
Lakeland Industries Inc
F:LLI
|
US |
Bankruptcy Probability
Santhera Pharmaceuticals Holding AG's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Santhera Pharmaceuticals Holding AG Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CH |
S
|
Santhera Pharmaceuticals Holding AG
SIX:SANN
|
244.2m CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
382.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
182.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
153.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
114.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
64.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
47.2B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Santhera Pharmaceuticals Holding AG's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Santhera Pharmaceuticals Holding AG has total debt of 2.4m CHF. This includes both short-term (0 CHF) and long-term (2.4m CHF) debt.
You can find a full breakdown on its Balance Sheet.
